Bioactive Compounds
-
BA2284 BofutrelvirSummary: Bofutrelvir (FB2001) is a major protease inhibitor of SARS-CoV-2. -
N1664 Nomilin - BA2283 MM3122Summary: MM3122 is a selective inhibitor of type II transmembrane serine proteases.
-
N1653 CrocinSummary: Natural carotenoid found in saffron - BA2282 YH-53Summary: YH-53 is a potent inhibitor.
-
N1633 Eleutheroside E - BA2281 BamlanivimabSummary: Bamlanivimab (Anti-HumanSARS-CoV-2) is the first COVID-19 monoclonal antibody (mAb) to receive Emergency Use Authorization (EUA) from the U.S. Food and Drug Administration (FDA) in November 2020.
-
N1606 Prim-O-glucosylcimifugin - BA2280 GRL-0496Summary: GRL-0496 is a potent chloropyridine ester-derived inhibitor.
- BA2279 X77Summary: X77 is a potent non-covalent bond inhibitor of the SARS-CoV-2 protease.